Nkarta, Inc. (NKTX)
2.26
+0.04
(+1.80%)
USD |
NASDAQ |
Oct 09, 16:00
2.26
0.00 (0.00%)
After-Hours: 20:00
Nkarta EPS Diluted (Quarterly) : -0.5419 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.5419 |
| March 31, 2026 | -0.3748 |
| December 31, 2025 | -0.3702 |
| September 30, 2025 | -0.2934 |
| June 30, 2025 | -0.3106 |
| March 31, 2025 | -0.4327 |
| December 31, 2024 | -0.3524 |
| September 30, 2024 | -0.3853 |
| June 30, 2024 | -0.3401 |
| March 31, 2024 | -0.5824 |
| December 31, 2023 | -0.5652 |
| September 30, 2023 | -0.5227 |
| June 30, 2023 | -0.6797 |
| March 31, 2023 | -0.6299 |
| December 31, 2022 | -0.6672 |
| Date | Value |
|---|---|
| September 30, 2022 | -0.5829 |
| June 30, 2022 | -0.6141 |
| March 31, 2022 | -0.7877 |
| December 31, 2021 | -0.6923 |
| September 30, 2021 | -0.6794 |
| June 30, 2021 | -0.656 |
| March 31, 2021 | -0.5917 |
| December 31, 2020 | -0.5488 |
| September 30, 2020 | -0.4204 |
| June 30, 2020 | -1.563 |
| March 31, 2020 | -0.2676 |
| December 31, 2019 | -0.3224 |
| September 30, 2019 | -0.0819 |
| June 30, 2019 | -0.1481 |
| March 31, 2019 | -0.0948 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.1822 |
| Alnylam Pharmaceuticals, Inc. | 1.207 |
| Savara, Inc. | -0.1587 |
| Vericel Corp. | 0.0422 |
| Biogen, Inc. | 0.6557 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -40.37M |
| Total Expenses (Quarterly) | 40.37M |
| Enterprise Value | 49.78M |
| Earnings Yield | -69.92% |
| Normalized Earnings Yield | -73.27 |